Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Shukra Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value(
)
524632
INE551C01028
10.1085326
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
N.A
27.42
507.81
EPS(TTM)
Face Value(
)
Div & Yield %:
4.23
10
0.04
Date
Headline
25-Apr-2024
Board of Shukra Pharmaceuticals allots 3.28 cr bonus shares
18-Mar-2024
Shukra Pharmaceuticals schedules board meeting
24-Feb-2024
Shukra Pharmaceuticals to conduct board meeting
05-Feb-2024
Shukra Pharmaceuticals to discuss results
03-Feb-2024
Shukra Pharmaceuticals Ltd - Board Meeting Intimation for For Considering And Approving The Unaudited Financial Result For The Quarter Ended On December 31 2023
03-Jan-2024
Shukra Pharmaceuticals Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
30-Dec-2023
Shukra Pharmaceuticals Ltd - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
30-Dec-2023
Shukra Pharmaceuticals Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
30-Dec-2023
Shukra Pharmaceuticals Ltd - Closure of Trading Window
22-Dec-2023
Shukra Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
1
2